CareDx Inc

CDNA

Company Profile

  • Business description

    CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

  • Contact

    8000 Marina Boulevard
    BrisbaneCA94005
    USA

    T: +1 415 287-2300

    E: [email protected]

    https://www.caredx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    650

Stocks News & Analysis

stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,151.800.100.00%
CAC 408,347.940.740.01%
DAX 4025,333.3887.28-0.34%
Dow JONES (US)49,191.99398.21-0.80%
FTSE 10010,174.9937.640.37%
HKSE26,999.81151.340.56%
NASDAQ23,709.8724.03-0.10%
Nikkei 22554,341.23792.071.48%
NZX 50 Index13,757.71101.660.74%
S&P 5006,963.7413.53-0.19%
S&P/ASX 2008,820.601.20-0.01%
SSE Composite Index4,126.0912.67-0.31%

Market Movers